Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New therapeutic options for cancer imparted in recent patents

Oct. 19, 2007

Physician's IND approved for Coramsine in U.S.

Oct. 19, 2007

Abraxis and FDA reach agreement through SPA for phase III Abraxane trial

Oct. 19, 2007

Only FDA-approved anthracycline extravasation kit reaches market

Oct. 18, 2007

Novel class I HDAC inhibitor developed at Merck & Co.

Oct. 18, 2007

FDA grants orphan drug status for tamibarotene in acute promyelocytic leukemia

Oct. 18, 2007

Expansion cohort in phase I Hedgehog antagonist trial initiated by Genentech

Oct. 18, 2007

Promising phase II data reported from ASA-404 phase II trial

Oct. 18, 2007

Threshold stops enrollment in phase II trial of glufosfamide

Oct. 18, 2007

BioCryst begins patient enrollment in pivotal forodesine trial

Oct. 18, 2007

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...